These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 1829104

  • 1. Recombinant outer surface protein a from Borrelia burgdorferi induces antibodies protective against spirochetal infection in mice.
    Simon MM, Schaible UE, Kramer MD, Eckerskorn C, Museteanu C, Müller-Hermelink HK, Wallich R.
    J Infect Dis; 1991 Jul; 164(1):123-32. PubMed ID: 1829104
    [Abstract] [Full Text] [Related]

  • 2. Immune sera to individual Borrelia burgdorferi isolates or recombinant OspA thereof protect SCID mice against infection with homologous strains but only partially or not at all against those of different OspA/OspB genotype.
    Schaible UE, Wallich R, Kramer MD, Gern L, Anderson JF, Museteanu C, Simon MM.
    Vaccine; 1993 Jul; 11(10):1049-54. PubMed ID: 8212826
    [Abstract] [Full Text] [Related]

  • 3. An OspA-based DNA vaccine protects mice against infection with Borrelia burgdorferi.
    Luke CJ, Carner K, Liang X, Barbour AG.
    J Infect Dis; 1997 Jan; 175(1):91-7. PubMed ID: 8985201
    [Abstract] [Full Text] [Related]

  • 4. Borrelia burgdorferi strain 25015: characterization of outer surface protein A and vaccination against infection.
    Fikrig E, Barthold SW, Persing DH, Sun X, Kantor FS, Flavell RA.
    J Immunol; 1992 Apr 01; 148(7):2256-60. PubMed ID: 1545130
    [Abstract] [Full Text] [Related]

  • 5. Roles of OspA, OspB, and flagellin in protective immunity to Lyme borreliosis in laboratory mice.
    Fikrig E, Barthold SW, Marcantonio N, Deponte K, Kantor FS, Flavell RA.
    Infect Immun; 1992 Feb 01; 60(2):657-61. PubMed ID: 1730500
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Artificial-infection protocols allow immunodetection of novel Borrelia burgdorferi antigens suitable as vaccine candidates against Lyme disease.
    Wallich R, Jahraus O, Stehle T, Tran TT, Brenner C, Hofmann H, Gern L, Simon MM.
    Eur J Immunol; 2003 Mar 01; 33(3):708-19. PubMed ID: 12616491
    [Abstract] [Full Text] [Related]

  • 8. Monoclonal antibodies specific for the outer surface protein A (OspA) of Borrelia burgdorferi prevent Lyme borreliosis in severe combined immunodeficiency (scid) mice.
    Schaible UE, Kramer MD, Eichmann K, Modolell M, Museteanu C, Simon MM.
    Proc Natl Acad Sci U S A; 1990 May 01; 87(10):3768-72. PubMed ID: 2339119
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A mouse model for Borrelia burgdorferi infection: pathogenesis, immune response and protection.
    Schaible UE, Wallich R, Kramer MD, Museteanu C, Simon MM.
    Behring Inst Mitt; 1991 Feb 01; (88):59-67. PubMed ID: 2049047
    [Abstract] [Full Text] [Related]

  • 13. Protection of mice against the Lyme disease agent by immunizing with recombinant OspA.
    Fikrig E, Barthold SW, Kantor FS, Flavell RA.
    Science; 1990 Oct 26; 250(4980):553-6. PubMed ID: 2237407
    [Abstract] [Full Text] [Related]

  • 14. A new approach to a Lyme disease vaccine.
    Livey I, O'Rourke M, Traweger A, Savidis-Dacho H, Crowe BA, Barrett PN, Yang X, Dunn JJ, Luft BJ.
    Clin Infect Dis; 2011 Feb 26; 52 Suppl 3():s266-70. PubMed ID: 21217174
    [Abstract] [Full Text] [Related]

  • 15. Comparison of protection in rabbits against host-adapted and cultivated Borrelia burgdorferi following infection-derived immunity or immunization with outer membrane vesicles or outer surface protein A.
    Shang ES, Champion CI, Wu XY, Skare JT, Blanco DR, Miller JN, Lovett MA.
    Infect Immun; 2000 Jul 26; 68(7):4189-99. PubMed ID: 10858236
    [Abstract] [Full Text] [Related]

  • 16. Protection of mice from Lyme borreliosis by oral vaccination with Escherichia coli expressing OspA.
    Fikrig E, Barthold SW, Kantor FS, Flavell RA.
    J Infect Dis; 1991 Dec 26; 164(6):1224-7. PubMed ID: 1955724
    [Abstract] [Full Text] [Related]

  • 17. Oral delivery of purified lipoprotein OspA protects mice from systemic infection with Borrelia burgdorferi.
    Luke CJ, Huebner RC, Kasmiersky V, Barbour AG.
    Vaccine; 1997 Dec 26; 15(6-7):739-46. PubMed ID: 9178476
    [Abstract] [Full Text] [Related]

  • 18. Immunization of mice by recombinant OspA preparations and protection against Borrelia burgdorferi infection induced by Ixodes ricinus tick bites.
    Gern L, Rais O, Capiau C, Hauser P, Lobet Y, Simoen E, Voet P, Pêtre J.
    Immunol Lett; 1994 Mar 26; 39(3):249-58. PubMed ID: 8034340
    [Abstract] [Full Text] [Related]

  • 19. Plasmid DNA and protein vaccination of mice to the outer surface protein A of Borrelia burgdorferi leads to induction of T helper cells with specificity for a major epitope and augmentation of protective IgG antibodies in vivo.
    Zhong W, Wiesmüller KH, Kramer MD, Wallich R, Simon MM.
    Eur J Immunol; 1996 Nov 26; 26(11):2749-57. PubMed ID: 8921965
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.